Fibrillin‐1 genetic deficiency leads to pathological ageing of arteries in mice
暂无分享,去创建一个
D. Quaglino | B. Starcher | M. Jacob | S. Bouillot | P. Huber | B. Mariko | G. Faury | F. Ramirez | B. Escoubet | M. Pezet | J. Andrieu
[1] Y. Usson,et al. Microfibrils and fibrillin-1 induce integrin-mediated signaling, proliferation and migration in human endothelial cells. , 2010, American journal of physiology. Cell physiology.
[2] R. Knutsen,et al. Discrete Contributions of Elastic Fiber Components to Arterial Development and Mechanical Compliance , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[3] Dean Y. Li,et al. Elastin haploinsufficiency induces alternative aging processes in the aorta. , 2008, Rejuvenation research.
[4] C. van Breemen,et al. Mechanical and Pharmacological Approaches to Investigate the Pathogenesis of Marfan Syndrome in the Abdominal Aorta , 2008, Journal of Vascular Research.
[5] R. Mecham,et al. New insights into elastic fiber assembly. , 2007, Birth defects research. Part C, Embryo today : reviews.
[6] Richard A Black,et al. The role of endothelial cell attachment to elastic fibre molecules in the enhancement of monolayer formation and retention, and the inhibition of smooth muscle cell recruitment. , 2007, Biomaterials.
[7] A. Dart,et al. Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial. , 2007, JAMA.
[8] D. Judge,et al. Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome , 2007, British journal of pharmacology.
[9] D. Keene,et al. Fibrillins 1 and 2 Perform Partially Overlapping Functions during Aortic Development* , 2006, Journal of Biological Chemistry.
[10] A. Vitarelli,et al. Aortic wall mechanics in the Marfan syndrome assessed by transesophageal tissue Doppler echocardiography. , 2006, The American journal of cardiology.
[11] J. Molkentin,et al. Temporally Controlled Onset of Dilated Cardiomyopathy Through Disruption of the SRF Gene in Adult Heart , 2005, Circulation.
[12] D. Gros,et al. Mouse Model of SCN5A-Linked Hereditary Lenègre’s Disease: Age-Related Conduction Slowing and Myocardial Fibrosis , 2005, Circulation.
[13] C. Baumgartner,et al. Diagnostic power of aortic elastic properties in young patients with Marfan syndrome. , 2005, The Journal of thoracic and cardiovascular surgery.
[14] Jessica Geubtner,et al. Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome. , 2004, The Journal of clinical investigation.
[15] Attila Kovacs,et al. Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiency. , 2003, The Journal of clinical investigation.
[16] Sarah E. Bernard,et al. Cell Adhesion to Fibrillin-1 Molecules and Microfibrils Is Mediated by α5β1 and αvβ3 Integrins* , 2003, Journal of Biological Chemistry.
[17] M. Jacob. Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[18] D. Arking,et al. Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome , 2003, Nature Genetics.
[19] K. Kivirikko,et al. Inactivation of the Lysyl Oxidase Gene Lox Leads to Aortic Aneurysms, Cardiovascular Dysfunction, and Perinatal Death in Mice , 2002, Circulation.
[20] D. Chitayat,et al. Connection between elastin haploinsufficiency and increased cell proliferation in patients with supravalvular aortic stenosis and Williams-Beuren syndrome. , 2002, American journal of human genetics.
[21] Clair Baldock,et al. Fibrillin: from microfibril assembly to biomechanical function. , 2002, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[22] Tasuku Honjo,et al. Fibulin-5/DANCE is essential for elastogenesis in vivo , 2002, Nature.
[23] H. Dietz,et al. Mouse models of genetic diseases resulting from mutations in elastic fiber proteins. , 2000, Matrix biology : journal of the International Society for Matrix Biology.
[24] H. Dietz,et al. Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[25] M. Lewis,et al. Endothelial function in Marfan syndrome: selective impairment of flow-mediated vasodilation. , 1999, Circulation.
[26] R. Mecham,et al. Novel arterial pathology in mice and humans hemizygous for elastin. , 1998, The Journal of clinical investigation.
[27] Dean Y. Li,et al. Elastin is an essential determinant of arterial morphogenesis , 1998, Nature.
[28] R. Mecham,et al. Action of tropoelastin and synthetic elastin sequences on vascular tone and on free Ca2+ level in human vascular endothelial cells. , 1998, Circulation research.
[29] H. Dietz,et al. Targetting of the gene encoding fibrillin–1 recapitulates the vascular aspect of Marfan syndrome , 1997, Nature Genetics.
[30] C. Morris,et al. Elastin point mutations cause an obstructive vascular disease, supravalvular aortic stenosis. , 1997, Human molecular genetics.
[31] G. Faury,et al. Effect of age on the vasodilatory action of elastin peptides , 1997, Mechanisms of Ageing and Development.
[32] S. Thibodeau,et al. A 30 kb deletion within the elastin gene results in familial supravalvular aortic stenosis. , 1995, Human molecular genetics.
[33] R. Mecham,et al. Identification of an Elastin Cross-linking Domain That Joins Three Peptide Chains , 1995, The Journal of Biological Chemistry.
[34] T W Redpath,et al. Aortic distensibility and stiffness index measured by magnetic resonance imaging in patients with Marfan's syndrome. , 1995, British heart journal.
[35] G. Belz,et al. Elastic properties and Windkessel function of the human aorta , 1995, Cardiovascular Drugs and Therapy.
[36] R. Jeremy,et al. Relation between age, arterial distensibility, and aortic dilatation in the Marfan syndrome. , 1994, The American journal of cardiology.
[37] C A Morris,et al. Supravalvular aortic stenosis associated with a deletion disrupting the elastin gene. , 1994, The Journal of clinical investigation.
[38] E. Davis. Immunolocalization of microfibril and microfibril-associated proteins in the subendothelial matrix of the developing mouse aorta. , 1994, Journal of cell science.
[39] Patricia Spallone,et al. Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome , 1993, Nature Genetics.
[40] M. Leppert,et al. A human vascular disorder, supravalvular aortic stenosis, maps to chromosome 7. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[41] Colleen A. Morris,et al. The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis , 1993, Cell.
[42] Ada Hamosh,et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene , 1991, Nature.
[43] R. Garrone,et al. A routine method for contrasting elastin at the ultrastructural level. , 1984, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[44] B. Baxter,et al. Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome. , 2008, Journal of vascular surgery.
[45] Sarah E. Bernard,et al. Cell adhesion to fibrillin-1 molecules and microfibrils is mediated by alpha 5 beta 1 and alpha v beta 3 integrins. , 2003, The Journal of biological chemistry.
[46] D. Arking,et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. , 2003, Nature genetics.
[47] Michael J Sherratt,et al. Elastic fibres. , 2002, Journal of cell science.
[48] G. Faury. Function-structure relationship of elastic arteries in evolution: from microfibrils to elastin and elastic fibres. , 2001, Pathologie-biologie.
[49] B. Starcher,et al. A role for neutrophil elastase in the progression of solar elastosis. , 1995, Connective tissue research.